Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.

Medicine - 15 Nov 2024

Xie Xiaowen, Dai Xinyue, Liu Huaxiang, Xing Yi

Abstract excerpt

This retrospective study aimed to investigate differences in clinical characteristics between different antibody phenotypes in patients with dermatomyositis (DM). Two hundred and ninety-three patients with DM were included in this study from September 2018 to September 2023. We collected basic clinical data from the patients, using statistical methods to analyze the clinical characteristics, and used survival...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Autoantibodies
Share to Dermatomyositis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-Induced Helicase, IFIH1

Share to Phenotype

Share to Prognosis

Share to Proportional Hazards Models

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 39560562
DOI: 10.1097/MD.0000000000040605
PMCID: PMC11575960

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.PMID 39560562Read ↗

Anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody dermatomyositis: Clinical features and outcomes in a racially diverse patient cohortSemantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.Semantic proximity Read ↗

Clinical phenotype and prognostic determinants of spontaneous pneumomediastinum in anti-MDA5 antibody-positive dermatomyositis.Semantic proximity Read ↗

Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon SystemSemantic proximity Read ↗

Efficacy and safety of a triple combination of glucocorticoids, tofacitinib and calcineurin inhibitors in anti-MDA5 positive dermatomyositisSemantic proximity Read ↗

Case Report: Anti-MDA-5 dermatomyositis in a resource-limited settingSemantic proximity Read ↗

Myositis-specific autoantibodies and their clinical associations in Idiopathic Inflammatory MyopathiesSemantic proximity Read ↗

Deep Pathological Phenotyping of Dermatomyositis with Different AutoantibodiesSemantic proximity Read ↗

Analysis of the correlation between anti-MDA5 antibody and the severity of COVID-19: a retrospective studySemantic proximity Read ↗

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicrySemantic proximity Read ↗

[The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.